KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $28.0 million.

  • Colgate Palmolive's Change in Receivables rose 12240.0% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.0 million, marking a year-over-year decrease of 6729.56%. This contributed to the annual value of $56.0 million for FY2024, which is 5135.14% up from last year.
  • Per Colgate Palmolive's latest filing, its Change in Receivables stood at $28.0 million for Q3 2025, which was up 12240.0% from -$22.0 million recorded in Q2 2025.
  • Colgate Palmolive's Change in Receivables' 5-year high stood at $252.0 million during Q1 2024, with a 5-year trough of -$128.0 million in Q4 2024.
  • Over the past 5 years, Colgate Palmolive's median Change in Receivables value was $18.0 million (recorded in 2021), while the average stood at $30.7 million.
  • Per our database at Business Quant, Colgate Palmolive's Change in Receivables surged by 101666.67% in 2023 and then plummeted by 41200.0% in 2024.
  • Colgate Palmolive's Change in Receivables (Quarter) stood at -$114.0 million in 2021, then skyrocketed by 149.12% to $56.0 million in 2022, then crashed by 144.64% to -$25.0 million in 2023, then plummeted by 412.0% to -$128.0 million in 2024, then soared by 121.88% to $28.0 million in 2025.
  • Its last three reported values are $28.0 million in Q3 2025, -$22.0 million for Q2 2025, and $174.0 million during Q1 2025.